Jubiliant Pharma seeking an acquisition in the US
DSIJ Intelligence / 21 Mar 2017
As Board of Directors approve to negotiate probable acquisitions, Singapore-based Jubiliant Pharma, the wholly owned subsidiary of Jubilant Life Science, heel up to expand its US operations.
Singapore-based Jubiliant Pharma, the wholly owned subsidiary of Jubilant Life Science is set to expand its US operations as the board of directors of Jubilant Pharma approved to negotiate a prospective acquisition of a specialty business in the US.
The company is seeking to acquire a specialty pharma business in the US by only using the means of internal accruals.
While the proposal, that is envisaged to be a profitable venture for the pharma major, will be subject to satisfactory agreements and diligence among others to attain a final approval of Jubilant Life Science. The move is also said to bring greater competitive edge to the pharma company.
As on March 21, 2017, the company's stock was trading at Rs 786.10, up by 0.10 per cent on the bourses.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.